Safety and Efficacy of Etigilimab in Combination with Nivolumab in Select Recurrent/advanced Solid Tumors.
Journal of Clinical Oncology(2022)
Key words
Intratumor Heterogeneity
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined